Defective intracellular transport of CLN3 is the molecular basis of Batten disease (JNCL) (vol 8, pg 1091, 1999)

被引：0
|
作者：
Järvelä, I
Lehtovirta, M
Tikkanen, R
Kyttälä, A
Jalanko, A
机构：
来源：
HUMAN MOLECULAR GENETICS | 1999年 / 8卷 / 08期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：1585 / 1585
页数：1
相关论文
共 19 条
  • [1] Defective intracellular transport of CLN3 is the molecular basis of Batten disease (JNCL)
    Järvelä, I
    Lehtovirta, M
    Tikkanen, R
    Kyttälä, A
    Jalanko, A
    HUMAN MOLECULAR GENETICS, 1999, 8 (06) : 1091 - 1098
  • [2] The natural history of juvenile Batten disease (JNCL; CLN3 disease)
    Mink, Jonathan
    Augustine, Erika F.
    Marshall, Frederick J.
    Adams, Heather R.
    Kwon, Jennifer M.
    Vierhile, Amy
    de Blieck, Elisabeth A.
    MOLECULAR GENETICS AND METABOLISM, 2013, 108 (02) : S66 - S66
  • [3] Biosynthesis and intracellular targeting of the CLN3 protein defective in Batten disease
    Järvelä, I
    Sainio, M
    Rantamäki, T
    Olkkonen, VM
    Carpén, O
    Peltonen, L
    Jalanko, A
    HUMAN MOLECULAR GENETICS, 1998, 7 (01) : 85 - 90
  • [4] Biosynthesis and subcellular localization of the CLN3 protein defective in Batten disease
    Jarvela, IE
    Sainio, M
    Rantamäki, T
    Olkkonen, V
    Carpen, O
    Peltonen, L
    Jalanko, A
    AMERICAN JOURNAL OF HUMAN GENETICS, 1997, 61 (04) : A253 - A253
  • [5] Targeted disruption of the Cln3 gene provides a mouse model for Batten disease (vol 6, pg 321, 1999)
    Mitchison, HM
    Bernard, DJ
    Greene, NDE
    Cooper, JD
    Junaid, MA
    Pullarkat, RK
    de Vos, N
    Breuning, MH
    Owens, JW
    Mobley, WC
    Gardiner, RM
    Lake, BD
    Taschner, PEM
    Nussbaum, RL
    NEUROBIOLOGY OF DISEASE, 2000, 7 (02) : 127 - 127
  • [6] Intracellular trafficking of CLN3, the protein underlying the childhood neurodegenerative disease, Batten disease
    Mao, QW
    Xia, HB
    Davidson, BL
    FEBS LETTERS, 2003, 555 (02) : 351 - 357
  • [7] A role in vacuolar arginine transport for yeast Btn1p and for human CLN3, the protein defective in Batten disease
    Kim, Y
    Ramirez-Montealegre, D
    Pearce, DA
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (26) : 15458 - 15462
  • [8] Neurodevelopmental delay in the Cln3Δex7/8 mouse model for Batten disease
    Osorio, N. S.
    Sampaio-Marques, B.
    Chan, C. -H.
    Oliveira, P.
    Pearce, D. A.
    Sousa, N.
    Rodrigues, F.
    GENES BRAIN AND BEHAVIOR, 2009, 8 (03) : 337 - 345
  • [9] Molecular screening of Batten disease: identification of a missense mutation (E295K) in the CLN3 gene
    N. Zhong
    Krystyna E. Wisniewski
    Alexandra L. Kaczmarski
    Weina Ju
    Wei Min Xu
    William W. Xu
    Lucilla Mclendon
    B. Liu
    Wojciech Kaczmarski
    Susan Sklower Brooks
    W. Ted Brown
    Human Genetics, 1998, 102 : 57 - 62
  • [10] Amlodipine prevents apoptotic cell death by correction of elevated intracellular calcium in a primary neuronal model of Batten disease (CLN3 disease)
    Warnock, Ashley
    Tan, Lu
    Li, Changhong
    Haack, Kristina An
    Narayan, Srinivas B.
    Bennett, Michael J.
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2013, 436 (04) : 645 - 649
12